Izidakamizwa "Rimantadine--STI"

Ukulungiselela "Rimantadine--STI" eyisidalwa esinenkululeko ethile chemotherapeutic, okuyinto has umsebenzi elwa namagciwane. It ikuvumela ukuba zivimbela synthesis imvilophi ezibangelwa amagciwane. Futhi lokhu ukulungiselela kuvimbela ukuthuthukiswa arboviruses elibangela encephalitis (Vector ngokuyinhloko izibungu).

Medicine "Rimantadine--STI" futhi akheka esibindini emva kwezinsuku 3 okwesihlanu uboniswa kanye umchamo ngendlela unmodified.

izinkomba

I nomuthi ingasetshenziswa izingane emva kweminyaka 7, uma kunesidingo, ukuphathwa kusaqalwa umkhuhlane. Kubantu abadala ingasetshenziswa njengoba nokuvimbela Umkhuhlane ngesikhathi ubhubhane yayo kanye nokuvinjelwa ezithwalwa encephalitis igciwane.

Tablets "Rimantadine--STI" - yokusetshenziswa

amaphilisi Izidakamizwa zigwinywa lonke bese beyihlanza ngamanzi, kungcono ukuthatha ke ngemva kokudla.

Lapho efeza zokuvimbela phakathi nenyanga ukuthatha esinye isibhebhe sibonisa ngosuku. Uma kwakuba khona ukudlula izidakamizwa, indlela elandelayo kwenziwa ngesikhathi esifanele futhi umthamo hhayi kabili. Ngaphambi kokuqala ukuthatha inkambo imithi "Rimantadine--STI" (amaphilisi), kubalulekile ukuba uthintane udokotela.

Uma usebenzisa le izidakamizwa olwenziwa ekwelapheni Umkhuhlane ezinganeni e engu eminyakeni 7-10 ubudala ngosuku kufanele baphuze amaphilisi amabili eneminyaka engu-11 eminyakeni engu-14 kunconywa ukuthatha ithebhulethi (50 mg) kathathu ngosuku. Ukwelashwa okufanayo abantu abadala kuhlanganisa phakathi nezinsuku zokuqala zokwelashwa engayitholi kathathu ngosuku, 2 amaphilisi nakho kungaba imali yesikhathi esisodwa ukuthatha isibalo esibekiwe (amaphilisi 6) zomuthi. Emini lesibili nelesithathu baphuze amaphilisi 2 kabili emini, futhi ngosuku 4th futhi wesi-5 inani elifanayo izidakamizwa, kodwa 1 ngosuku. Ngokuvamile, isikhathi imithi "Rimantadine--STI" ihlala hhayi ningi than izinsuku 5.

Ezimweni lapho isidingo nokuvinjelwa viral ezithwalwa encephalitis izingane, umuthi kufanele libekwe kuphela udokotela. Thatha le Ikhambi kufanele kube ngokushesha nje ngemva kokulunywa umkhaza. Abadala kufanele kube izinsuku ezintathu, baphuze amaphilisi 2 kabili ngosuku, reception ngezinye izikhathi lungaboniswa izinsuku ezinhlanu. Kulezo zimo lapho, ngemva kokulunywa umkhaza bekulokhu izinsuku ezingaphezu kwezingu-2, kuphuzwa imithi "Rimantadine--STI" kwenza akukho mqondo. Uma uya nokuhamba izindawo lapho kukhona esengozini yokungenwa yigciwane le ezithwalwa entsifalitom viral, ungasebenzisa izidakamizwa njengoba isilinganiso izifo, ngisho ngaphandle ngemva kokulunywa umkhaza. Ezimweni ezinjalo, izinsuku ezingu-15 ukuthatha esinye isibhebhe sibonisa, kodwa lokhu kungenziwa kuphela abantu abadala, izingane lena indlela akwamukeleki lokuvikela.

Imiphumela engemihle

Ezimweni eziningi, izidakamizwa "Rimantadine--STI 'ebekezelele ngokubhekakade kahle. Kodwa ngezinye izikhathi kungase namanje:

• dyspepsia, ukukhishwa yisisu kanye nokuba ukuqubuka;
• tinnitus, ataxia, ukucindezeleka, ukozela, hoarseness, ukuyaluza.

Izimo

Izidakamizwa "Rimantadine--STI" is alinikeziwe kulezi zimo ezilandelayo:

• ebukhoneni oyingozi futhi ezingalapheki izinso izifo, futhi izifo zesibindi acute;
• ngesikhathi lactation, kanye ngesikhathi sokukhulelwa;
• ebukhoneni hypersensitive adamantane nemikhiqizo noma ezinye izingxenye;
• thyrotoxicosis.

Phakathi ukwelashwa nale izidakamizwa is hhayi Kunconywa ukuba baphuze utshwala ngoba lokho kungabangela abantu basabele ngendlela embi phezu ingxenye isimiso sezinzwa esiyinhloko. Ukwamukelwa acetylsalicylic acid paracetamol iyehlisa umphumela izidakamizwa wathi.

ukweqisa izidakamizwa

Okwedlulele umthamo watusa zomuthi ukuze isetshenziswe abantu kungabangela ukuhhema, ukuqhanyelwa yanda, futhi arrhythmia inhliziyo, okuyinto ezimweni ezingajwayelekile kungaholela kuze kube ngisho nasekufeni. Lapho ukweqisa izidakamizwa kuyadingeka ukuze ukuqhuba ukwelashwa nge fizostigminoma, 1-2 mg abadala kanye izingane ngokwanele 0.5 mg.